Related references
Note: Only part of the references are listed.Melatonin therapy reduces the risk of osteoporosis and normalizes bone formation in multiple sclerosis
Majid Ghareghani et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2018)
Spasticity Treatment Ameliorates the Efficacy of Melatonin Therapy in Experimental Autoimmune Encephalomyelitis (EAE) Mouse Model of Multiple Sclerosis
Majid Ghareghani et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)
Neuroprotective Effects of Melatonin on Experimental Allergic Encephalomyelitis Mice Via Anti-Oxidative Stress Activity
Ting Long et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2018)
Efficacy of Melatonin on Serum Pro-inflammatory Cytokines and Oxidative Stress Markers in Relapsing Remitting Multiple Sclerosis
Angelica L. Sanchez-Lopez et al.
ARCHIVES OF MEDICAL RESEARCH (2018)
Melatonin Increases Oligodendrocyte Differentiation in Cultured Neural Stem Cells
Majid Ghareghani et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2017)
Melatonin exacerbates acute experimental autoimmune encephalomyelitis by enhancing the serum levels of lactate: A potential biomarker of multiple sclerosis progression
Majid Ghareghani et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2017)
Neurodegeneration in multiple sclerosis and neuromyelitis optica
Izumi Kawachi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
The Peroxisome-Mitochondria Connection: How and Why?
Marc Fransen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis
Rebecca M. Heidker et al.
NEURAL REGENERATION RESEARCH (2017)
Expression profiles of cholesterol metabolism-related genes are altered during development of experimental autoimmune encephalomyelitis in the rat spinal cord
Irena Lavrnja et al.
SCIENTIFIC REPORTS (2017)
Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis
Shyi-Jou Chen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Extracellular N-Acetylaspartate in Human Traumatic Brain Injury
Richard J. Shannon et al.
JOURNAL OF NEUROTRAUMA (2016)
Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis
Frederic Sedel et al.
NEUROPHARMACOLOGY (2016)
Metabolic Interplay between Peroxisomes and Other Subcellular Organelles Including Mitochondria and the Endoplasmic Reticulum
Ronald J. A. Wanders et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance
Nuria Alvarez-Sanchez et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Progressive multiple sclerosis 1 Pathological mechanisms in progressive multiple sclerosis
Don H. Mahad et al.
LANCET NEUROLOGY (2015)
WHITE MATTER LACTATE - DOES IT MATTER?
J. E. Rinholm et al.
NEUROSCIENCE (2014)
Differential brain and spinal cord cytokine and BDNF levels in experimental autoimmune encephalomyelitis are modulated by prior and regular exercise
Danielle Bernardes et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
One calcitriol dose transiently increases Helios+FoxP3+ T cells and ameliorates autoimmune demyelinating disease
Faye E. Nashold et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Cerebral Developmental Abnormalities in a Mouse with Systemic Pyruvate Dehydrogenase Deficiency
Lioudmila Pliss et al.
PLOS ONE (2013)
Pyruvate Dehydrogenase Kinases in the Nervous System: Their Principal Functions in Neuronal-glial Metabolic Interaction and Neuro-metabolic Disorders
Mithilesh Kumar Jha et al.
Current Neuropharmacology (2012)
Panglial Gap Junctional Communication is Essential for Maintenance of Myelin in the CNS
Oliver Tress et al.
JOURNAL OF NEUROSCIENCE (2012)
Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis
Lena Melamud et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Oligodendroglia metabolically support axons and contribute to neurodegeneration
Youngjin Lee et al.
NATURE (2012)
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Ursula Fuenfschilling et al.
NATURE (2012)
Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm
Helena Batoulis et al.
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2010)
The cytosolic redox state of astrocytes: Maintenance, regulation and functional implications for metabolite trafficking
Johannes Hirrlinger et al.
BRAIN RESEARCH REVIEWS (2010)
Myocardial Fatty Acid Metabolism in Health and Disease
Gary D. Lopaschuk et al.
PHYSIOLOGICAL REVIEWS (2010)
Central nervous system: cholesterol turnover, brain development and neurodegeneration
John M. Dietschy
BIOLOGICAL CHEMISTRY (2009)
A modern approach to the treatment of mitochondrial disease
Sumit Parikh et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2009)
Melatonin Promotes Oligodendroglial Maturation of Injured White Matter in Neonatal Rats
Paul Olivier et al.
PLOS ONE (2009)
Mitochondrial defects in acute multiple sclerosis lesions
Don Mahad et al.
BRAIN (2008)
Agomelatine, a melatonin receptor agonist with 5-HT2C receptor antagonist properties, protects the developing murine white matter against excitotoxicity
Pierre Gressens et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Melatonin as a naturally occurring co-substrate of quinone reductase-2, the putative MT3 melatonin membrane receptor:: hypothesis and significance
Dun-Xian Tan et al.
JOURNAL OF PINEAL RESEARCH (2007)
The involvement of mitochondria in the pathogenesis of multiple sclerosis
Bernadette Kalman et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis
S. Cader et al.
NEUROIMAGE (2007)
Melatonin: therapeutic and clinical utilization
A. Altun et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)
Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion
Anne-Karin Welin et al.
PEDIATRIC RESEARCH (2007)
N-acetylaspartate in the CNS:: From neurodiagnostics to neurobiology
John R. Moffett et al.
PROGRESS IN NEUROBIOLOGY (2007)
Effects of melatonin and age on gene expression in mouse CNS using microarray analysis
Edward H. Sharman et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Fluoxetine increases cerebral white matter NAA/Cr ratio in patients with multiple sclerosis
JP Mostert et al.
NEUROSCIENCE LETTERS (2006)
Axonal metabolic recovery and potential neuroprotective effect of glatiramer acetate in relapsing-remitting multiple sclerosis
O Khan et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
High cholesterol level is essential for myelin membrane growth
G Saher et al.
NATURE NEUROSCIENCE (2005)
Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis
M Inglese et al.
NEUROIMAGE (2004)
Melatonin and mitochondrial function
J Leon et al.
LIFE SCIENCES (2004)
Biochemical and structural brain alterations in female mice with cerebral pyruvate dehydrogenase deficiency
L Pliss et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Prophylactic use of melatonin protects against focal cerebral ischemia in mice:: role of endothelin converting enzyme-1
E Kilic et al.
JOURNAL OF PINEAL RESEARCH (2004)
Brain cholesterol:: Long secret life behind a barrier
I Björkhem et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Peroxisomal membrane monocarboxylate transporters: evidence for a redox shuttle system?
GB McClelland et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Genomic scale profiling of autoimmune inflammation in the central nervous system: the nervous response to inflammation
RJ Carmody et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Phenotypic analysis of mice deficient in the major myelin protein MOBP, and evidence for a novel Mobp isoform
D Yool et al.
GLIA (2002)
Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge
I Husson et al.
ANNALS OF NEUROLOGY (2002)
Parameters related to lipid metabolism as markers of myelination in mouse brain
ED Muse et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Axonal metabolic recovery in multiple sclerosis patients treated with interferon β-1b
S Narayanan et al.
JOURNAL OF NEUROLOGY (2001)
Inactivation of the murine pyruvate dehydrogenase (Pdha1) gene and its effect on early embryonic development
MT Johnson et al.
MOLECULAR GENETICS AND METABOLISM (2001)
N-acetylaspartate reduction as a measure of injury severity and mitochondrial dysfunction following diffuse traumatic brain injury
S Signoretti et al.
JOURNAL OF NEUROTRAUMA (2001)
Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis:: evidence for myelin-associated aspartoacylase
G Chakraborty et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Share Paper
